Diagnos Inc. (ADK.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 70 | 492 | 138 | 219 | 105 |
| Marketable Securities | 2,750 | 2,000 | 500 | N/A | 200 |
| Receivables | 104 | 81 | 174 | 148 | 179 |
| TOTAL | $3,025 | $2,646 | $878 | $407 | $551 |
| Non-Current Assets | |||||
| PPE Net | 171 | 200 | 225 | 257 | 287 |
| TOTAL | $171 | $200 | $225 | $257 | $287 |
| Total Assets | $3,197 | $2,846 | $1,104 | $664 | $838 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,674 | 1,794 | 1,794 | 976 | 185 |
| Accounts payable and accrued liabilities | 219 | 300 | 177 | 330 | 339 |
| Accrued Expenses | 169 | 200 | 139 | 191 | 162 |
| TOTAL | $3,178 | $2,418 | $2,236 | $1,622 | $790 |
| Non-Current Liabilities | |||||
| Long Term Debt | 431 | 1,249 | 1,186 | 1,946 | 2,723 |
| Deferred Revenues | 0 | 8 | 10 | 8 | 20 |
| TOTAL | $496 | $1,342 | $1,306 | $2,094 | $2,930 |
| Total Liabilities | $3,674 | $3,760 | $3,542 | $3,716 | $3,720 |
| Shareholders' Equity | |||||
| Common Shares | 43,042 | 41,509 | 38,996 | 37,700 | 37,000 |
| Retained earnings | -53,596 | -52,383 | -51,364 | -50,647 | -49,838 |
| Other shareholders' equity | 10,077 | 9,959 | 9,928 | 9,895 | 9,957 |
| TOTAL | $-477 | $-915 | $-2,439 | $-3,052 | $-2,882 |
| Total Liabilities And Equity | $3,197 | $2,846 | $1,104 | $664 | $838 |